Glucaric acid

Glucaric acid is a lipid of Fatty Acyls (FA) class. Glucaric acid is associated with abnormalities such as Consumption-archaic term for TB and furuncle. The involved functions are known as Oxidation, Mutation, Process, Cell Growth and Anabolism. Glucaric acid often locates in BL21, Clone and host. The associated genes with Glucaric acid are MIOX gene, ISYNA1 gene, Genome and Candidate Disease Gene. The related experimental models are Knock-out.

Cross Reference

Introduction

To understand associated biological information of Glucaric acid, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Glucaric acid?

Glucaric acid is suspected in and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Glucaric acid

MeSH term MeSH ID Detail
Alcoholism D000437 27 associated lipids
Hyperinsulinism D006946 27 associated lipids
Kidney Diseases D007674 29 associated lipids
Kidney Neoplasms D007680 29 associated lipids
Liver Diseases D008107 31 associated lipids
Hypertension, Pulmonary D006976 32 associated lipids
Micronuclei, Chromosome-Defective D048629 33 associated lipids
Hyperplasia D006965 34 associated lipids
Acute Kidney Injury D058186 34 associated lipids
Epilepsy D004827 35 associated lipids
Per page 10 20 50 100 | Total 85

PubChem Associated disorders and diseases

What pathways are associated with Glucaric acid

Lipid pathways are not clear in current pathway databases. We organized associated pathways with Glucaric acid through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Glucaric acid?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Glucaric acid?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Glucaric acid?

There are no associated biomedical information in the current reference collection.

What genes are associated with Glucaric acid?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Glucaric acid?

Knock-out

Knock-out are used in the study 'Evolution-guided optimization of biosynthetic pathways.' (Raman S et al., 2014).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Glucaric acid

Download all related citations
Per page 10 20 50 100 | Total 1061
Authors Title Published Journal PubMed Link
Fujimoto T et al. A new clinical prognostic predictor for patients with biliary atresia. 1994 J. Pediatr. Surg. pmid:8078014
Cassimos C et al. Urinary D-glucaric acid excretion in children with dystonic reactions caused by antiemetic drugs. 1975 J. Pediatr. pmid:1185409
Cassimos C et al. Urinary D-glucaric acid excretion in normal and G-6-PD-deficient children with favism. 1974 J. Pediatr. pmid:4826626
Meyer MP et al. A comparison of oral and intravenous iron supplementation in preterm infants receiving recombinant erythropoietin. 1996 J. Pediatr. pmid:8765624
Gehret TC et al. Convenient large-scale synthesis of D-glucaro-1,4:6,3-dilactone. 2009 J. Org. Chem. pmid:19777999
Kochhar PK et al. Intravenous iron sucrose versus oral iron in treatment of iron deficiency anemia in pregnancy: a randomized clinical trial. 2013 J. Obstet. Gynaecol. Res. pmid:22925176
Devasenapathy N et al. Is intravenous iron sucrose the treatment of choice for pregnant anemic women? 2013 J. Obstet. Gynaecol. Res. pmid:23167561
Krafft A and Breymann C Iron sucrose with and without recombinant erythropoietin for the treatment of severe postpartum anemia: a prospective, randomized, open-label study. 2011 J. Obstet. Gynaecol. Res. pmid:21159035
Mariani G et al. Detection of acute myocardial infarction by 99mTc-labeled D-glucaric acid imaging in patients with acute chest pain. 1999 J. Nucl. Med. pmid:10565778
Okada DR et al. Early detection of infarct in reperfused canine myocardium using 99mTc-glucarate. 2004 J. Nucl. Med. pmid:15073263
Yaoita H et al. Localization of technetium-99m-glucarate in zones of acute cerebral injury. 1991 J. Nucl. Med. pmid:1704054
Willerson JT Detection of acute myocardial infarcts by infarct-avid imaging. 1991 J. Nucl. Med. pmid:1846912
Ballinger JR et al. Effect of hypoxia on the accumulation of technetium-99m-glucarate and technetium-99m-gluconate by Chinese hamster ovary cells in vitro. 1993 J. Nucl. Med. pmid:8381475
Orlandi C et al. Early scintigraphic detection of experimental myocardial infarction in dogs with technetium-99m-glucaric acid. 1991 J. Nucl. Med. pmid:1992031
Liu Z et al. High-resolution imaging with (99m)Tc-glucarate for assessing myocardial injury in rat heart models exposed to different durations of ischemia with reperfusion. 2004 J. Nucl. Med. pmid:15235074
Oberhaensli RD et al. Different actions of deferoxamine and iron on Ga-67 abscess detection in rats. 1984 J. Nucl. Med. pmid:6587029
Ohtani H et al. Comparison of technetium-99m-glucarate and thallium-201 for the identification of acute myocardial infarction in rats. 1992 J. Nucl. Med. pmid:1432160
Yaoita H et al. Distribution of deoxyglucose and technetium-99m-glucarate in the acutely ischemic myocardium. 1993 J. Nucl. Med. pmid:8326389
Usmanov RI et al. Intravenous iron without erythropoietin for the treatment of iron deficiency anemia in patients with moderate to severe congestive heart failure and chronic kidney insufficiency. 2008 Mar-Apr J. Nephrol. pmid:18446719
Kowalczyk M et al. Ferumoxytol: a new era of iron deficiency anemia treatment for patients with chronic kidney disease. 2011 Nov-Dec J. Nephrol. pmid:21956770
Kumbasar A et al. The effect of different doses and types of intravenous iron on oxidative stress and inflammation in hemodialysis patients. 2012 Sep-Oct J. Nephrol. pmid:22307439
Leijn E et al. Intravenous iron supplementation in children on hemodialysis. 2004 May-Jun J. Nephrol. pmid:15365964
Abou-Issa H et al. Chemotherapeutic evaluation of glucarate and N-(4-hydroxyphenyl)retinamide alone and in combination in the rat mammary tumor model. 1989 J. Natl. Cancer Inst. pmid:2531231
Froessler B et al. Intravenous iron sucrose versus oral iron ferrous sulfate for antenatal and postpartum iron deficiency anemia: a randomized trial. 2013 J. Matern. Fetal. Neonatal. Med. pmid:23130909
Agarwal R Ironing out the mystery of nephrotoxicity of parenteral iron. 2005 J. Lab. Clin. Med. pmid:16025083
Sanai T et al. Effect of saccharated ferric oxide and iron dextran on the metabolism of phosphorus in rats. 2005 J. Lab. Clin. Med. pmid:16025088
Cazzola M Recombinant human erythropoietin to assist autologous blood donation by patients with anemia. 1997 J. Lab. Clin. Med. pmid:9358072
Rycroft D and Daniel JW The excretion of D-glucaric acid in the urine of human volunteers following the administration of disopyramide. 1976 J. Int. Med. Res. pmid:1026531
Monsénégo J et al. Enhancing liver mitochondrial fatty acid oxidation capacity in obese mice improves insulin sensitivity independently of hepatic steatosis. 2012 J. Hepatol. pmid:22037024
Roberton AM et al. Two genes affecting glucarate utilization in Escherichia coli K12. 1980 J. Gen. Microbiol. pmid:6999115
RICHTER GW The cellular transformation of injected colloidal iron complexes into ferritin and hemosiderin in experimental animals; a study with the aid of electron microscopy. 1959 J. Exp. Med. pmid:13620849
ELLIS JT Glomerular lesions and the nephrotic syndrome in rabbits given saccharated iron oxide intravenously; with special reference to the part played by intracapillary precipitates in the pathogenesis of the lesions. 1956 J. Exp. Med. pmid:13278460
Zanor MI et al. Metabolic characterization of loci affecting sensory attributes in tomato allows an assessment of the influence of the levels of primary metabolites and volatile organic contents. 2009 J. Exp. Bot. pmid:19346240
Dwivedi C et al. Modulation of chemically initiated and promoted skin tumorigenesis in CD-1 mice by dietary glucarate. 1989 May-Jun J. Environ. Pathol. Toxicol. Oncol. pmid:2509679
Singh J and Gupta KP Induction of apoptosis by calcium D-glucarate in 7,12-dimethyl benz [a] anthracene-exposed mouse skin. 2007 J. Environ. Pathol. Toxicol. Oncol. pmid:17725531
da Silva Krause M et al. Physiological concentrations of interleukin-6 directly promote insulin secretion, signal transduction, nitric oxide release, and redox status in a clonal pancreatic β-cell line and mouse islets. 2012 J. Endocrinol. pmid:22761278
Gargan R et al. A concise biotyping system for differentiating strains of Escherichia coli. 1982 J. Clin. Pathol. pmid:6757274
Tutor JC et al. Urinary excretion of D-glucaric acid in porphyria cutanea tarda. 1987 J. Clin. Chem. Clin. Biochem. pmid:2895161
Walters DG et al. Direct determination of D-[U-14C] glucaric acid in urine by ion-exchange high-performance liquid chromatography. 1983 J. Chromatogr. pmid:6423654
Laakso EI et al. Determination of D-glucaric acid by high-performance liquid chromatography. 1983 J. Chromatogr. pmid:6668320
Comín-Colet J et al. A pilot evaluation of the long-term effect of combined therapy with intravenous iron sucrose and erythropoietin in elderly patients with advanced chronic heart failure and cardio-renal anemia syndrome: influence on neurohormonal activation and clinical outcomes. 2009 J. Card. Fail. pmid:19879457
Beck-da-Silva L et al. Rationale and design of the IRON-HF study: a randomized trial to assess the effects of iron supplementation in heart failure patients with anemia. 2007 J. Card. Fail. pmid:17338998
Sricholpech M et al. Lysyl hydroxylase 3-mediated glucosylation in type I collagen: molecular loci and biological significance. 2012 J. Biol. Chem. pmid:22573318
Aghaie A et al. New insights into the alternative D-glucarate degradation pathway. 2008 J. Biol. Chem. pmid:18364348
Lawrence MC et al. Calcineurin/nuclear factor of activated T cells and MAPK signaling induce TNF-{alpha} gene expression in pancreatic islet endocrine cells. 2011 J. Biol. Chem. pmid:21059644
Watanabe S et al. alpha-ketoglutaric semialdehyde dehydrogenase isozymes involved in metabolic pathways of D-glucarate, D-galactarate, and hydroxy-L-proline. Molecular and metabolic convergent evolution. 2007 J. Biol. Chem. pmid:17202142
Vanderford NL The role of MafA in regulating cytokine expression in pancreatic beta cells. 2011 J. Biol. Chem. pmid:21239506
Nakajima M et al. Metastatic melanoma cell heparanase. Characterization of heparan sulfate degradation fragments produced by B16 melanoma endoglucuronidase. 1984 J. Biol. Chem. pmid:6698965
Glaser JH and Conrad HE Chondroitin SO4 catabolism in chick embryo chondrocytes. 1979 J. Biol. Chem. pmid:570972
Bhattacharya S et al. Prophylactic role of D-Saccharic acid-1,4-lactone in tertiary butyl hydroperoxide induced cytotoxicity and cell death of murine hepatocytes via mitochondria-dependent pathways. 2011 Nov-Dec J. Biochem. Mol. Toxicol. pmid:21538728
Monterrubio R et al. A common regulator for the operons encoding the enzymes involved in D-galactarate, D-glucarate, and D-glycerate utilization in Escherichia coli. 2000 J. Bacteriol. pmid:10762278
Yoon SH et al. Cloning and characterization of uronate dehydrogenases from two pseudomonads and Agrobacterium tumefaciens strain C58. 2009 J. Bacteriol. pmid:19060141
Spiegel K et al. Sleep loss: a novel risk factor for insulin resistance and Type 2 diabetes. 2005 J. Appl. Physiol. pmid:16227462
Tryfinopoulou P et al. Diversity of Shewanella population in fish Sparus aurata harvested in the Aegean Sea. 2007 J. Appl. Microbiol. pmid:17714405
Reeves DS et al. Pharmacokinetics of tetroxoprim and sulphadiazine in human volunteers. 1979 J. Antimicrob. Chemother. pmid:536337
Furuno K et al. Preventive effect of D-glucarate against renal damage induced by kanamycin. 1976 J. Antibiot. pmid:993134
Furuno K et al. Effect of D-Glucarates on basic antibiotic-induced renal damage in rats. 1976 J. Antibiot. pmid:931801
Kuo KL et al. Intravenous iron exacerbates oxidative DNA damage in peripheral blood lymphocytes in chronic hemodialysis patients. 2008 J. Am. Soc. Nephrol. pmid:18495964
Scheiber-Mojdehkar B et al. Non-transferrin-bound iron in the serum of hemodialysis patients who receive ferric saccharate: no correlation to peroxide generation. 2004 J. Am. Soc. Nephrol. pmid:15153577
Kuo KL et al. Iron sucrose accelerates early atherogenesis by increasing superoxide production and upregulating adhesion molecules in CKD. 2014 J. Am. Soc. Nephrol. pmid:24722448
Bolger AP et al. Intravenous iron alone for the treatment of anemia in patients with chronic heart failure. 2006 J. Am. Coll. Cardiol. pmid:16979010
Toblli JE et al. Intravenous iron reduces NT-pro-brain natriuretic peptide in anemic patients with chronic heart failure and renal insufficiency. 2007 J. Am. Coll. Cardiol. pmid:17950147
Francis GS and Kanderian A Anemia and heart failure a new pathway? 2007 J. Am. Coll. Cardiol. pmid:17950148
Liu Y et al. New poly(d-glucaramidoamine)s induce DNA nanoparticle formation and efficient gene delivery into mammalian cells. 2004 J. Am. Chem. Soc. pmid:15198572
Liu Y and Reineke TM Hydroxyl stereochemistry and amine number within poly(glycoamidoamine)s affect intracellular DNA delivery. 2005 J. Am. Chem. Soc. pmid:15740138
Durlofsky L and Fruncillo RJ Impaired drug-metabolizing ability in the burned rat. 1982 J Trauma pmid:7143502
Walters KR et al. Methamphetamine causes anorexia in Drosophila melanogaster, exhausting metabolic reserves and contributing to mortality. 2012 J Toxicol Sci pmid:22863857
Collinot JP et al. Evaluation of urinary D-glucaric acid excretion in workers exposed to butyl glycol. 1996 J Toxicol Environ Health pmid:8691506
Walaszek Z et al. Repression by sustained-release beta-glucuronidase inhibitors of chemical carcinogen-mediated induction of a marker oncofetal protein in rodents. 1988 J Toxicol Environ Health pmid:3336058
Steinberg KK et al. Assessment of 2,3,7,8-tetrachlorodibenzo-p-dioxin exposure using a modified D-glucaric acid assay. 1985 J Toxicol Environ Health pmid:4093993
Fenwick S and Peebles G Total dose infusion of intravenous iron in patients with chronic kidney disease receiving haemodialysis. 2011 J Ren Care pmid:21288317
Elford P et al. Biodistribution and predictive hepatic gene expression of intravenous iron sucrose. 2013 Nov-Dec J Pharmacol Toxicol Methods pmid:23624021
Lai AA and Levy RH Pharmacokinetic description of drug interactions by enzyme induction: carbamazepine-clonazepam in monkeys. 1979 J Pharm Sci pmid:108383
Tutor-Crespo M et al. Isoforms of serum gamma-glutamyltransferase in epileptic patients treated with enzyme-inducing anticonvulsant drugs. 2004 J Pharm Pharm Sci pmid:15576017
Lu QY et al. Overestimation of flavonoid aglycones as a result of the ex vivo deconjugation of glucuronides by the tissue β-glucuronidase. 2014 J Pharm Biomed Anal pmid:24176739
Christoph P et al. Intravenous iron treatment in pregnancy: comparison of high-dose ferric carboxymaltose vs. iron sucrose. 2012 J Perinat Med pmid:22945271
Pfenniger A et al. Safety and efficacy of high-dose intravenous iron carboxymaltose vs. iron sucrose for treatment of postpartum anemia. 2012 J Perinat Med pmid:22752771
Németh I et al. Hyperbilirubinemia and urinary D-glucaric acid excretion in premature infants following antepartum dexamethasone treatment. 1981 J Perinat Med pmid:6783743
Breymann C et al. Milk iron content in breast-feeding mothers after administration of intravenous iron sucrose complex. 2007 J Perinat Med pmid:17302514
Wali A et al. Comparative study--efficacy, safety and compliance of intravenous iron sucrose and intramuscular iron sorbitol in iron deficiency anemia of pregnancy. 2002 J Pak Med Assoc pmid:12532571
Nasir A et al. Management of iron deficiency anaemia in gynaecological patients at Jinnah Postgraduate Medical Centre, Karachi. 2011 J Pak Med Assoc pmid:22356035
Gambini JP et al. Evaluation of patients with head and neck cancer by means of 99mTc-glucarate. 2009 J Nucl Med Technol pmid:19949020
Okada DR et al. Myocardial kinetics of Tc-99m glucarate in low flow, hypoxia, and aglycemia. 2003 Mar-Apr J Nucl Cardiol pmid:12673182
Beanlands RS et al. Differentiation of myocardial ischemia and necrosis by technetium 99m glucaric acid kinetics. 1997 Jul-Aug J Nucl Cardiol pmid:9278873
Khaw BA et al. Avidity of technetium 99m glucarate for the necrotic myocardium: in vivo and in vitro assessment. 1997 Jul-Aug J Nucl Cardiol pmid:9278874
Johnson LL et al. Technetium-99m glucarate uptake in a swine model of limited flow plus increased demand. 2000 Nov-Dec J Nucl Cardiol pmid:11144474
Auerbach M and Ballard H Intravenous iron in oncology. 2008 J Natl Compr Canc Netw pmid:18597712
Laman CA et al. Parenteral iron therapy: a single institution's experience over a 5-year period. 2005 J Natl Compr Canc Netw pmid:16316614
Wilson PD et al. An analysis of the health service efficiency and patient experience with two different intravenous iron preparations in a UK anaemia clinic. 2013 J Med Econ pmid:22989163
Al-Saran KA and Sabry AA Pregnancy in dialysis patients: a case series. 2008 J Med Case Rep pmid:18205953
Breymann C Treatment of iron deficiency anaemia in pregnancy and postpartum with special focus on intravenous iron sucrose complex. 2005 J Med Assoc Thai pmid:17718296
Reinisch W et al. State of the iron: how to diagnose and efficiently treat iron deficiency anemia in inflammatory bowel disease. 2013 J Crohns Colitis pmid:22917870
Bager P and Dahlerup JF The health care cost of intravenous iron treatment in IBD patients depends on the economic evaluation perspective. 2010 J Crohns Colitis pmid:21122539
Tutor-Crespo MJ et al. Possible induction of cholinesterase in epileptic patients treated with anticonvulsant drugs: relationship with lipoprotein levels. 2004 J Clin Pharmacol pmid:15317825
Toyokuni S Mysterious link between iron overload and CDKN2A/2B. 2011 J Clin Biochem Nutr pmid:21297911
RICHTER GW Intranuclear aggregates of ferritin in liver cells of mice treated with saccharated iron oxide. Their possible relation to nuclear protein synthesis. 1961 J Biophys Biochem Cytol pmid:13741388
Moorani KN and Asim S Parenteral iron sucrose in iron deficiency anaemia of paediatric chronic kidney disease. 2011 Jul-Sep J Ayub Med Coll Abbottabad pmid:23272434
Costa S et al. In vitro evaluation of the chemoprotective action mechanisms of leontopodic acid against aflatoxin B1 and deoxynivalenol-induced cell damage. 2009 J Appl Toxicol pmid:18636399
Poon R et al. HPLC determination of D-glucaric acid in human urine. 1993 May-Jun J Anal Toxicol pmid:8336488
Steinberg KK and Needham LL A comparison of two methods for quantifying D-glucaric acid. 1986 Jul-Aug J Anal Toxicol pmid:3747452